The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Regulatory News (COST)

Share Price Information for Costain (COST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 83.40
Bid: 83.00
Ask: 84.00
Change: -0.60 (-0.71%)
Spread: 1.00 (1.205%)
Open: 82.60
High: 84.20
Low: 82.60
Prev. Close: 84.00
COST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Year End Trading Update

3 Jan 2019 07:00

RNS Number : 0078M
Costain Group PLC
03 January 2019
 

3 January 2019

 

Costain Group PLC

("Costain" or "the Group" or "the Company")

 

 

Year End Trading Update

 

Costain, the smart infrastructure solutions company, today issues a trading update ahead of announcing results for the year ended 31 December 2018 on 6 March 2019.

 

The Group has continued to perform well in the second half and expects to deliver full-year results in line with the Board's expectations.

 

This year has seen the Group make further progress on its strategy of transforming Costain into the UK's leading smart infrastructure solutions company. Costain is differentiating itself through its long-term strategic relationships and integrated technology-enabled services necessitated by the increasingly complex and fast-changing nature of its clients' requirements. The Group continues to be involved in a number of major regulatory-driven procurement processes.

 

The Group has finished the year with an order book at a record level of £4.2 billion (31 December 2017: £3.9 billion), reflecting Costain's market position with its target clients who are consolidating their supply chains to deliver increasingly large, multi-billion pound investment programmes underpinned by regulatory commitments. In addition, the Group's preferred bidder position stands at c £600 million (31 December 2017: £400 million).

The Group finished the year with a strong net cash position of over £110 million, in line with expectations, (31 December 2017: £177.7million) with the reduction from last year's exceptionally high level due to the timing of receipts in that period. Throughout the year the Group had a positive net cash position with an average month-end net cash balance of c £77 million (2017: £96.7 million).

Andrew Wyllie CBE, chief executive, said:

"This has been another year of progress for Costain. The benefits of our integrated offering, long-term strategic relationships with our clients and strong balance sheet position us well for the future and the significant opportunity we see across our rapidly-changing end markets."

 

 

Enquiries:

 

Costain

Tel: 01628 842 444

Andrew Wyllie CBE, Chief Executive

Tony Bickerstaff, Chief Financial Officer

Carolyn Rich, Investor Relations Director

Sara Lipscombe, Group Communications Director

Instinctif Partners

Tel: 020 7457 2020

Mark Garraway

James Gray

 

 

Notes to Editors

 

Costain helps to improve people's lives by deploying technology-based engineering solutions to meet urgent national needs across the UK's energy, water and transportation infrastructures. We have been shaping the world in which we live for the past 150 years.

 

The Group's 'Engineering Tomorrow' strategy involves focusing on blue chip clients in chosen sectors whose major spending plans are underpinned by strategic national needs, regulatory commitments or essential maintenance requirements.

 

Costain's 4,000 people are committed to high performance and safe delivery. They are delivering a broad range of innovative services including consultancy, technology, asset optimisation and complex delivery services across a range of high profile contracts in the UK incorporating the whole life cycle of our clients' assets.

 

For more information visit www.costain.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTBTMFTMBJMBAL
Date   Source Headline
5th May 20224:47 pmRNSResult of AGM
5th May 20227:00 amRNSTrading in line with market expectations
4th May 20228:55 amRNSLONG TERM INCENTIVE PLAN – LISTING APPLICATION
6th Apr 20225:24 pmRNSGrant of Share Plan Awards
30th Mar 202210:30 amRNSNotice of AGM and Annual Report and Accounts
28th Mar 20227:00 amRNSDirectorate Change
25th Mar 20224:35 pmRNSPrice Monitoring Extension
10th Mar 20224:36 pmRNSPrice Monitoring Extension
9th Mar 20227:00 amRNSDirectorate Change
9th Mar 20227:00 amRNSStrong performance in 2021
24th Feb 20227:00 amRNSPeterborough & Huntingdon contract resolution
12th Jan 20227:00 amRNSDirectorate Change
4th Jan 202210:00 amRNSBlock Listing Six Monthly Return
13th Dec 20217:00 amRNSUpdate on P&H contract and current trading
10th Nov 202110:49 amRNSDirector/PDMR Shareholding
2nd Nov 20211:33 pmRNSDirector/PDMR Shareholding
28th Sep 20217:00 amRNSAppointment of non-executive director
17th Sep 20214:36 pmRNSPrice Monitoring Extension
25th Aug 20217:00 amRNSInterim Results
15th Jul 20217:00 amRNSHalf Year Trading Update
1st Jul 202110:30 amRNSBlock Listing Six Monthly Return
6th May 20213:45 pmRNSResults of 2021 AGM
6th May 20217:00 amRNSAGM Statement
20th Apr 20212:00 pmRNSDealings in Costain Shares
8th Apr 20214:05 pmRNSLong Term Incentive Plan Awards
8th Apr 20219:00 amRNSExercise of Nil Cost Options
1st Apr 20219:34 amRNSNotice of AGM and Annual Report and Accounts
16th Mar 20217:00 amRNSResults For The Year Ended 31 December 2020
4th Mar 20211:40 pmRNSNotice of Results
24th Feb 20211:30 pmRNSHolding(s) in Company
17th Feb 20217:00 amRNSSettlement Agreement relating to the A465 contract
27th Jan 20217:00 amRNSBoard changes
22nd Jan 202110:15 amRNSNOTIFICATION OF MAJOR HOLDINGS
5th Jan 20217:00 amRNSYear End Trading Update
4th Jan 202110:05 amRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20209:42 amRNSLong Term Incentive Plan Award
20th Nov 20207:00 amRNSAppointment of Chief Financial Officer
3rd Nov 20204:14 pmRNSDirector/PDMR Shareholding
29th Oct 20207:10 amRNSBoard Notification - External Directorship
7th Oct 202012:10 pmRNSLong Term Incentive Plan Awards
5th Oct 20207:00 amRNSDirectorate Change
24th Sep 20209:20 amRNSHolding(s) in Company
14th Sep 20207:00 amRNSResults for the half year ended 30 June 2020
9th Sep 20201:08 pmRNSHolding(s) in Company
3rd Sep 20207:00 amRNSUpdate on the A465 contract
17th Aug 20207:00 amRNSTrading Update and Revised Date of Half Year
7th Aug 202012:07 pmRNSSecond Price Monitoring Extn
7th Aug 202012:02 pmRNSPrice Monitoring Extension
5th Aug 20202:09 pmRNSHolding(s) in Company
31st Jul 20207:05 amRNSBoard Notification – External Directorship

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.